Alexandra Calmy

22.9k total citations · 3 hit papers
305 papers, 10.1k citations indexed

About

Alexandra Calmy is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Alexandra Calmy has authored 305 papers receiving a total of 10.1k indexed citations (citations by other indexed papers that have themselves been cited), including 209 papers in Infectious Diseases, 123 papers in Virology and 94 papers in Emergency Medicine. Recurrent topics in Alexandra Calmy's work include HIV/AIDS Research and Interventions (141 papers), HIV Research and Treatment (117 papers) and HIV/AIDS drug development and treatment (117 papers). Alexandra Calmy is often cited by papers focused on HIV/AIDS Research and Interventions (141 papers), HIV Research and Treatment (117 papers) and HIV/AIDS drug development and treatment (117 papers). Alexandra Calmy collaborates with scholars based in Switzerland, United States and France. Alexandra Calmy's co-authors include Matthias Cavassini, Enos Bernasconi, Bernard Hirschel, Nathan Ford, Hansjakob Furrer, Manuel Battegay, Marco Vitória, Bruno Ledergerber, Nathan Ford and Huldrych F. Günthard and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Alexandra Calmy

284 papers receiving 9.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Markers of Inflammation, Coagulation, and Renal Function Are Elevated in Adults with HIV Infection

2010 660 citations Alexandra Calmy et al. profile →
Cognitive dysfunction in HIV patients despite long-standing suppression of viremia

2010 538 citations Matthias Cavassini, Alexandra Calmy et al. AIDS profile →
Major revision version 12.0 of the European AIDS Clinical Society guidelines 2023

2023 75 citations Jean‐Michel Molina, Alexandra Calmy et al. HIV Medicine profile →

Peers

Countries citing papers authored by Alexandra Calmy

Since Specialization

Citations

This map shows the geographic impact of Alexandra Calmy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandra Calmy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandra Calmy more than expected).

Fields of papers citing papers by Alexandra Calmy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandra Calmy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandra Calmy. The network helps show where Alexandra Calmy may publish in the future.

Co-authorship network of co-authors of Alexandra Calmy

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandra Calmy. A scholar is included among the top collaborators of Alexandra Calmy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandra Calmy. Alexandra Calmy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tecovirimat at a crossroads: What the PALM007 trial tells us 2025 ·Med ·Olivier Ségéral, (unknown), Alexandra Calmy	0
2	Switch to fixed-dose doravirine (100 mg) with islatravir (0·75 mg) once daily in virologically suppressed adults with HIV-1 on antiretroviral therapy: 48-week results of a phase 3, randomised, open-label, non-inferiority trial 2024 ·The Lancet HIV ·Jean‐Michel Molina, Giuliano Rizzardini, Catherine Orrell, (unknown), Alexandra Calmy, Shinichi Oka, Federico Hinestrosa, (unknown), Pablo Tebas, Sharon Walmsley, Anjana Grandhi, Stephanie O. Klopfer, Isaias Noel Gendrano, Karen Eves, (unknown), (unknown), Jason Kim	10
3	Patient and public involvement in HIV research: a mapping review and development of an online evidence map 2024 ·Journal of the International AIDS Society ·David Jackson‐Perry, (unknown), David Haerry, (unknown), (unknown), Alexandra Calmy, Marie Ballif, Chloé Pasin, Julia Notter, Alain Amstutz, (unknown)	0
4	SARS-CoV-2 m-RNA Vaccine Response in Immunocompromised Patients: A Monocentric Study Comparing Cancer, People Living with HIV, Hematopoietic Stem Cell Transplant Patients and Lung Transplant Recipients 2023 ·Vaccines ·Natacha Bordry, Anne‐Claire Mamez, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Sabine Yerly, (unknown), (unknown), Mariagrazia Di Marco, Nicolas Mach, Paola M. Soccal, Yves Chalandon, Alexandra Calmy, Alfredo Addeo	1
5	An Automated Literature Review Tool (LiteRev) for Streamlining and Accelerating Research Using Natural Language Processing and Machine Learning: Descriptive Performance Evaluation Study 2023 ·Journal of Medical Internet Research ·(unknown), Iza Ciglenečki, Amaury Thiabaud, (unknown), Alexandra Calmy, Olivia Keiser, (unknown)	11
6	External validation of the Dat'AIDS score: A risk score for predicting 5‐year overall mortality in people living with HIV aged 60 years or older 2023 ·HIV Medicine ·Maxime Hentzien, Jaromil Frossard, Roger D. Kouyos, Virginie Prendki, (unknown), (unknown), Dominique L. Braun, Patrick Schmid, Enos Bernasconi, (unknown), Orestis Efthimiou, Cyrille Delpierre, Clotilde Allavena, Firouzé Bani‐Sadr, Alexandra Calmy, (unknown)	0
7	Long‐term trends in hepatitis C prevalence, treatment uptake and liver‐related events in the Swiss HIV Cohort Study 2023 ·Liver International ·Lukas Baumann, Dominique L. Braun, Matthias Cavassini, Marcel Stoeckle, Enos Bernasconi, Patrick Schmid, Alexandra Calmy, David Haerry, Charles Béguelin, Christoph A. Fux, Gilles Wandeler, Bernard Surial, Andri Rauch	1
8	Real-Life Therapeutic Concentration Monitoring of Long-Acting Cabotegravir and Rilpivirine: Preliminary Results of an Ongoing Prospective Observational Study in Switzerland 2022 ·Pharmaceutics ·(unknown), (unknown), (unknown), Aline Munting, Matthias Cavassini, Dominique L. Braun, Huldrych F. Günthard, Katharina Kusejko, Bernard Surial, Hansjakob Furrer, Andri Rauch, (unknown), Alexandra Calmy, Marcel Stoeckle, Manuel Battegay, Catia Marzolini, Pascal André, Monia Guidi, Thierry Buclin, Laurent A. Décosterd, (unknown)	10
9	Dexamethasone exposure in normal‐weight and obese hospitalized COVID‐19 patients: An observational exploratory trial 2022 ·Clinical and Translational Science ·(unknown), Pauline Gosselin, Stéphane Guerrier, Youssef Daali, Jules Desmeules, Olivier Grosgurin, Jean‐Luc Reny, Caroline Samer, Alexandra Calmy, (unknown)	8
10	Female Genital Mutilation/Cutting in the Swiss HIV Cohort Study: A Cross-Sectional Study 2022 ·Journal of Immigrant and Minority Health ·(unknown), Sara Cottler-Casanova, Matthias Cavassini, Marcel Stoeckle, Gilles Wandeler, Patrick Schmid, Dominique L. Braun, Alexandra Scherrer, Enos Bernasconi, Alexandra Calmy, Jasmine Abdulcadir	3
11	Women with HIV transitioning through menopause: Insights from the Swiss HIV Cohort Study (SHCS) 2022 ·HIV Medicine ·Anna Hachfeld, Andrew Atkinson, Petra Stute, Alexandra Calmy, Philip Tarr, Katharine Darling, Baharak Babouee Flury, (unknown), (unknown), Irène A. Abela, Karoline Aebi‐Popp, (unknown)	8
12	Accelerating investigation of new HIV drugs in pregnancy: advancing the research agenda from theory to action 2022 ·Journal of the International AIDS Society ·Martina Penazzato, Shahin Lockman, Angela Colbers, Françoise Renaud, Alexandra Calmy, Polly Clayden, (unknown), Imelda Mahaka, (unknown), Cadi Irvine, Elaine J. Abrams, (unknown)	6
13	Therapeutic anticoagulation to prevent thrombosis, coagulopathy, and mortality in severe COVID‐19: The Swiss COVID‐HEP randomized clinical trial 2022 ·Research and Practice in Thrombosis and Haemostasis ·Marc Blondon, Sara Cereghetti, Jérôme Pugin, Christophe Marti, Pauline Darbellay Farhoumand, Jean‐Luc Reny, Alexandra Calmy, Christophe Combescure, Lucia Mazzolai, Olivier Pantet, (unknown), Marie Méan, (unknown), (unknown), Hans Stricker, Helia Robert‐Ebadi, Pierre Fontana, Marc Righini, Alessandro Casini	18
14	Weight and Metabolic Changes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living With HIV 2021 ·Annals of Internal Medicine ·Bernard Surial, Catrina Mugglin, Alexandra Calmy, Matthias Cavassini, Huldrych F. Günthard, M Stöckle, Enos Bernasconi, Patrick Schmid, Philip Tarr, Hansjakob Furrer, Bruno Ledergerber, Gilles Wandeler, Andri Rauch, (unknown)	79
15	The Impact of Binge Drinking on Mortality and Liver Disease in the Swiss HIV Cohort Study 2021 ·Journal of Clinical Medicine ·Bernard Surial, Nicolas Bertholet, Jean‐Bernard Daeppen, Katharine Darling, Alexandra Calmy, Huldrych F. Günthard, M Stöckle, Enos Bernasconi, Patrick Schmid, Andri Rauch, Hansjakob Furrer, Gilles Wandeler, (unknown)	11
16	Cardiovascular risk assessment in people living with HIV compared to the general population 2021 ·European Journal of Preventive Cardiology ·(unknown), Matthias Cavassini, (unknown), (unknown), Alexandra Calmy, Barbara Hasse, Heiner C. Bucher, (unknown), Olivier Müller, Marie Méan, Péter Vollenweider, Pedro Marques‐Vidal, Julien Vaucher	15
17	Dexamethasone and remdesivir: finding method in the COVID-19 madness 2020 ·The Lancet Microbe ·Pauline Vetter, Laurent Kaiser, Alexandra Calmy, Thomas Agoritsas, Angela Huttner	10
18	Adverse events of raltegravir and dolutegravir 2017 ·AIDS ·Luigia Elzi, Stefan Erb, Hansjakob Furrer, Matthias Cavassini, Alexandra Calmy, Pietro Vernazza, Huldrych F. Günthard, Enos Bernasconi, Manuel Battegay	86
19	Emergence of Acquired HIV-1 Drug Resistance Almost Stopped in Switzerland: A 15-Year Prospective Cohort Analysis 2016 ·Clinical Infectious Diseases ·Alexandra Scherrer, Viktor von Wyl, Wan-Lin Yang, Roger D. Kouyos, Jürg Böni, Sabine Yerly, Thomas Klimkait, Vincent Aubert, Matthias Cavassini, Manuel Battegay, Hansjakob Furrer, Alexandra Calmy, Pietro Vernazza, Enos Bernasconi, Huldrych F. Günthard	39
20	Hit me with your best shot 2015 ·AIDS ·Jennifer Cohn, Linda‐Gail Bekker, Helen Bygrave, Alexandra Calmy	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact